Genu Recurvatum Market Overview and Future Developments Insights Shared In Detailed Report
Avail FREE
Sample Here: https://www.marketresearchfuture.com/sample_request/4812
Genu Recurvatum is a rare
orthopedic complication in which the hyperextension of the knee is greater than
five degrees. It is also known as back knee or knee hyperextension. It occurs
more frequently in females than it does in males, and is commonly, identified
in 0.5% - 1.0% of patients undergoing Total knee arthroplasty (TKA). This
condition causes stress in the posterior knee structures which cause permanent
damage of the joint.
It is estimated that genu
recurvatum market is expected to grow at a CAGR 4.5% during the forecast period
of 2017-2023.
Market Key
Players
Some of key the players in the market are DePuy Synthes Companies (Part of
Johnson & Johnson Services, Inc.), Globus Medical, Inc., Medtronic plc,
NuVasive, Inc., Smith & Nephew plc, Stryker Corporation, Zimmer Inc and
others.
Industry
Segmentation
The Genu
recurvatum market is segmented on the basis of type, diagnosis, treatment, and
end-user.
On the basis of type,
market is segmented into external rotatory deformity (ERD), internal rotatory
deformity (IRD), and non-rotatory deformity (NRD).
On the basis of diagnosis,
market is segmented into magnetic resonance imaging (MRI), X-rays, and others.
On the basis of treatment,
market is classified into physical therapy, orthoses, bracing, and surgery.
On the basis of end-user,
market is segmented into hospital, clinics, and others.
Genu recurvatum can be
congenital or acquired. Congenital genu recurvatum (CGR) is an extremely rare
condition, and found to be associated with other malformations such as talipes
equinovarus, hip dysplasia, and absent patella. Signs and symptoms of this
medical condition includes pain in the inner-leg portion of knee also known as
medial tibiofemoral joint, pain in the outer back portion of knee also known as
posterolateral ligamentous structures, extension of gait pattern, and
difficulty in performing endurance activities. Genu recurvatum can be of three
types, i.e. external rotatory deformity (ERD), internal rotatory deformity
(IRD), and non-rotatory deformity (NRD). Out of three, ERD, and NRD are more
severe, as ERD leads to soft tissue damage in which lower legs angle outward.
Whereas, NRD, produces stress to the posterior soft tissue structures of knee.
In some developing, and under developed regions, burden of orthopedics
condition is rising due to lack of awareness. According to a study published in
Indian Journal of Orthopaedics (IJO) in 2016, deficient orthopedic services and
education such as, poor surgeon–patient ratio, poorly trained physicians to
deal with musculoskeletal emergencies, and absence of minimum standard of
orthopedic care, have been observed in some part of India. However, the Indian
Orthopaedic Association (IOA) along with government health planners, individual
medical practitioners, and medical educationists are working to find remedial
solutions to these problems.
Browse
Complete Premium Report Details at: https://www.marketresearchfuture.com/reports/genu-recurvatum-market-4812
Notably, the market is
expected to expand in the near future due to rise in geriatric population, high
unmet needs of current treatment, and increase in research and development
expenditure. Increase in aging population is the major market driver because
the risk of orthopedic disorders increases exponentially with age. According to
the data suggested by WHO in 2015, it is found that, worldwide, one in eight
people was aged 60 years or over and by 2030, older people are projected to
account for one in six people globally.
Despite these drivers,
there are some issues associated with genu recurvatum market. High cost of
treatment & management of genu recurvatum and related disorders, and lack
of infrastructure in middle and low income countries may hamper the growth of
the market.
Intended
Audience
- Hospitals
- Surgical equipment Companies
- Diagnostic clinics
- Research and Development (R&D)
Companies
- Government Research Institute
- Academic Institutes and
Universities
Regional
Analysis
The Americas dominate the
Genu recurvatum market owing to the rising awareness among people and
increasing healthcare expenditure. Centers for Disease Control and Prevention
(CDC) has stated that out of the total annual healthcare expenditure, 86% is
for people with chronic health conditions in the United States. Furthermore,
increasing participation of bigger players and new marketers towards
advancement in treatment approaches have also attracted a great deal of
attention.
Ask for
any Help Or Query at: https://www.marketresearchfuture.com/enquiry/4812
Europe holds the second
position in the Genu recurvatum market. It is expected that the support
provided by government bodies for research & development and improvement in
reimbursement policies in healthcare will drive the market in the European
region.
Asia Pacific is the fastest
growing genu recurvatum market owing to the huge patient pool and developing
healthcare technology.
The Middle East &
Africa has the lowest market for rabies treatment market due to lack of
technical knowledge and poor medical facilities.
About
Market Research Future:
At Market Research Future
(MRFR), we enable our customers to unravel the complexity of various industries
through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR),
Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research
& Consulting Services.
In order to stay updated
with technology and work process of the industry, MRFR often plans &
conducts meet with the industry experts and industrial visits for its research
analyst members.
Contact:
Market Research Future
+1 646 845 9312
Comments
Post a Comment